Jane Street Group, LLC Genocea Biosciences, Inc. Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$0.01 - $1.38 $184 - $25,437	-18,433 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$0.96 - $1.35 $17,695 - $24,884	18,433 New	18,433 $23,000
Q4 2020 Feb 17, 2021	SELL	$1.91 - $2.67 $27,710 - $38,736	-14,508 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$1.81 - $5.53 $26,259 - $80,229	14,508 New	14,508 $33,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.